Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate

NCT01222026 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Primary Hyperparathyroidism
Osteopenia
Osteoporosis

Interventions

DRUG: Strontium Ranelate + Ca/Vitamin-D
DRUG: Placebo

Sponsor

Medical University of Vienna

Collaborators

[object Object]